# Invenshure

Invenshure is an Asset Manager based in Minneapolis, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Minneapolis, United States
- **Region:** North America
- **Address:** Minneapolis, MN, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** invenshure.com
- **LinkedIn:** https://www.linkedin.com/company/invenshure-llc

## Regulatory record

- **Reports private funds:** No

## About

Invenshure is a Minneapolis-based company founded in 2011. It has secured $5.71 million in total funding.

## Sectors

- AI/ML
- Digital Health
- Enterprise Software
- Medical Devices
- Robotics & Automation

## People

- Danny Cunagin — Co-Founder & Managing Partner
- Troy Kopischke — Co-Founder & Partner

## Questions

### How does Invenshure's company-creation model differ from a conventional venture capital fund?

Invenshure originates intellectual property internally or in close partnership with research institutions rather than evaluating third-party pitch decks as its primary sourcing channel. The firm often co-invents the foundational technology, recruits management, and leads the earliest capital formation, retaining significant ownership and board influence through clinical or commercial proof points. This makes Invenshure more comparable to a venture studio or an internal corporate R&D function than a standard LP-backed fund.

### What is Invenshure's relationship with the Mayo Clinic and University of Minnesota?

Both institutions represent consistent sources of proprietary deal flow for the firm. Invenshure has structured multiple companies around technology licensed from the Mayo Clinic and the University of Minnesota, leveraging Minneapolis’s strong academic-medical research corridor. The specific licensing and revenue-share terms are negotiated on a per-company basis and are not publicly disclosed.

### Who runs investment decisions at Invenshure?

Co-founders Danny Cunagin (Managing Partner) and Troy Kopischke (Partner) lead the firm’s investment and company-building decisions. Cunagin’s background includes prior operating and venture roles in medical technology, while Kopischke brings experience in venture formation and deal structuring. The firm does not maintain a large investment committee; decisions are made by the partners alongside domain-specific scientific advisors on a case-by-case basis.

## Related profiles

- [Chainalysis](https://altss.com/profile/chainalysis-inc)
- [e-LogiT](https://altss.com/profile/e-logit-co)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/invenshure

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology